Position in GILD
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$274,926,696
+$46,370,825 QoQ
Shares Held
1,972,639
+5.9% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 94%
None 6%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $11,353,030,401 across 14 Drug Manufacturers - General names. GILD ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,347,394 | $3,998,602,577 | |
| 2 | AZN |
Astrazeneca PLC
|
11,949,424 | $2,356,665,399 | |
| 3 | JNJ |
Johnson & Johnson
|
7,872,478 | $1,924,348,519 | |
| 4 | ABBV |
AbbVie Inc.
|
6,931,036 | $1,507,431,018 | |
| 5 | AMGN |
Amgen Inc
|
1,107,159 | $389,553,892 | |
| 6 | NVS |
Novartis AG
|
2,275,938 | $347,649,529 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,880,199 | $346,459,135 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
1,972,639 | $274,926,696 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $274,926,696 | 1,972,639 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $228,555,871 | 1,862,114 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $184,089,282 | 1,658,462 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $125,451,288 | 1,131,517 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $81,619,124 | 728,417 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $119,718,631 | 1,296,077 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $147,689,273 | 1,761,561 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $114,132,323 | 1,663,494 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $125,531,674 | 1,713,743 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $143,379,598 | 1,769,900 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $141,534,830 | 1,888,642 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $147,786,886 | 1,917,567 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $133,312,543 | 1,606,756 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $174,958,005 | 2,037,950 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $131,542,819 | 2,132,320 | Shares | Defined | 2023-01-13 | |
| 2022-06-30 | $180,232,580 | 2,915,913 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $315,993,751 | 5,315,286 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $387,579,836 | 5,337,830 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $382,103,179 | 5,470,339 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $360,588,626 | 5,236,547 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $288,348,748 | 4,461,531 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $289,640,696 | 4,971,519 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $333,569,962 | 5,278,841 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $450,534,249 | 5,855,657 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $432,990,108 | 5,791,735 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||